CWM
NUVB icon

Cornerstone Wealth Management’s Nuvation Bio NUVB Stock Holding History

Cornerstone Wealth Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$61.9K Sell
11,045
-297
-3% -$1.86K ﹤0.01% 744
2026
Q2 		$64.4K Hold
11,342
– – ﹤0.01% 734
2026
Q1 		$48.7K Buy
11,342
+150
+1% +$836 ﹤0.01% 701
2025
Q4 		$100K Buy
+11,192
New +$69.3K 0.01% 677

Other funds holding NUVB

Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ACPLP
ACT Capital Partners, L.P. Wayne, Pennsylvania $154M AUM
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Cornerstone Wealth Management's NUVB Position: Q3 2026 in Review

Cornerstone Wealth Management reduced its Nuvation Bio (NUVB) stake by 2.6% in Q3 2026, selling an estimated $1.86K and leaving 11,045 shares worth $61.9K. The position accounts for ﹤0.01% of the portfolio, ranked #744.

Cornerstone Wealth Management first reported a position in NUVB in Q4 2025 and has held it in 4 quarters since. The position peaked at $100K in Q4 2025. 87 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • Cornerstone Wealth Management held 11,045 shares of Nuvation Bio worth $61.9K as of Q3 2026.
  • Cornerstone Wealth Management sold 297 Nuvation Bio shares in Q3 2026, an estimated $1.86K.
  • Nuvation Bio made up ﹤0.01% of Cornerstone Wealth Management's portfolio in Q3 2026, its #744 holding.
  • Cornerstone Wealth Management first reported a position in Nuvation Bio in Q4 2025 and has held it in 4 quarters since.
  • Cornerstone Wealth Management's Nuvation Bio position peaked at $100K in Q4 2025.
  • 87 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on Cornerstone Wealth Management's 13F filing for Q3 2026, filed 4 Nov 2026.